Siemens Medical and the United States enter the field of third-party medical imaging diagnostic center

On December 1st, Siemens Medical Systems Co., Ltd. (hereinafter referred to as “Siemens Medical China”) and Mei Nian Health Industry Holdings Co., Ltd. (hereinafter referred to as “Ministry of Health”) jointly announced that the two parties signed an agreement and will jointly establish Operates an independent medical imaging diagnostic center. Yu Rong, Chairman of Midea Health Industry Holdings Co., Ltd., President Xu Ke, Michael Reitermann, Global Chief Operating Officer of Siemens Medical, and Zeng Fanzhong, President of Siemens Medical Greater China attended the signing ceremony.

On the same day, the US-based Health, which was listed on the Shenzhen Stock Exchange, issued the “Announcement on Establishing a Joint Venture with Siemens Medical Systems Co., Ltd.”. According to the announcement, Siemens Medical will establish a joint venture with Mei Nian Health to establish Shanghai Meixi Medical Diagnostics Co., Ltd. Named), the total investment amount is RMB 100 million. Among them, Midea Health intends to invest RMB 51 million with its own funds and hold 51% of the equity of the joint venture company; Siemens Medical intends to invest RMB 49 million to hold the joint venture 49% of the company's equity.

The joint venture company will have a board of directors. The board of directors will consist of five members. Three members (including the chairman) will be appointed by Mei Nian Health, and the other two members will be appointed by Siemens Medical. Each party has the right to nominate one supervisor. The general manager was nominated by Mei Nian Health and one of the chief financial officers was nominated by Siemens Medical.

It is understood that the center will be located in Shanghai in the future, covering an area of ​​about 3,000 square meters, and will use imaging equipment, in vitro diagnostics and other advanced equipment and other medical products for image diagnosis, health inspection and in vitro diagnosis.

On August 12, 2016, the National Health and Family Planning Commission officially issued the notice of “Basic Standards and Management Regulations for Medical Imaging Diagnosis Center (Trial)”, which laid a foundation for the development of domestic third-party medical imaging diagnostic centers.

According to the Notice, the Medical Imaging Diagnostic Center is a separate medical institution. It is an independent legal entity and independently assumes corresponding legal responsibilities. It encourages the medical imaging diagnostic center to form a chain and group, and establish a standardized and standardized management and service model. For the applicants who intend to start a group-based and chain-based medical imaging diagnosis center, approval can be given priority.

After the "Notice" was released, some insiders said that in the future, large-scale imaging diagnostic equipment manufacturers may be involved in the medical service industry through the form of third-party medical imaging diagnostic centers, on the one hand to meet the needs of the deep development of their industrial chain, on the other hand To achieve the advancement of its data collection, optimization, and development, in addition, it also contributes to the sales of its related equipment.

Michael Reitermann, Chief Operating Officer, Siemens Global Healthcare

Glucoside Powder

Glucoside Powder,Spirulina Powder,Green Tea Extract Powder,Jujube Seed Extract Powder

Shaanxi Changsheng Industrial Co., Ltd. , https://www.cncsbio.com